FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2963855109> ?p ?o ?g. }

• W2963855109 endingPage "347.e2" @default.
• W2963855109 startingPage "332" @default.
• W2963855109 abstract "Quality of life (QoL) is not included among the end points in many studies, and QoL results are underreported in many phase 3 oncology trials. We performed a systematic review to describe QoL prevalence and heterogeneity in QoL reporting in recently published prostate cancer phase 3 trials. A PubMed search was performed to identify primary publications of randomized phase 3 trials testing anticancer drugs in prostate cancer, issued between 2012 and 2018. We analyzed QoL inclusion among end points, presence of QoL results, and methodology of QoL analysis. Seventy-two publications were identified (15 early-stage, 20 advanced hormone-sensitive, and 37 castration-resistant prostate cancer [CRPC]). QoL was not listed among study end points in 23 studies (31.9%) (40.0% early stage, 40.0% advanced hormone sensitive, and 24.3% CRPC). QoL results were absent in 15 (30.6%) of 49 primary publications of trials that included QoL among end points. Overall, as a result of absent end point or unpublished results, QoL data were lacking in 38 (52.8%) primary publications (53.3% early stage, 55.0% in advanced hormone sensitive, and 51.4% in CRPC). The most commonly used QoL tools were Functional Assessment of Cancer Therapy–Prostate (FACT-P) (21, 53.8%) and European Organization for Research and Treatment of Cancer Quality of Life Questionnaire–Core 30 (EORTC QLQ-C30) (14, 35.9%); most common methods of analysis were mean changes or mean scores (28, 71.8%), time to deterioration (14, 35.9%), and proportion of patients with response (10, 25.6%). In conclusion, QoL data are lacking in a not negligible proportion of recently published phase 3 trials in prostate cancer, although the presence of QoL results is better in positive trials, especially in CRPC. The methodology of QoL analysis is heterogeneous for type of instruments, analysis, and presentation of results." @default.
• W2963855109 created "2019-07-30" @default.
• W2963855109 creator A5000621664 @default.
• W2963855109 creator A5001428569 @default.
• W2963855109 creator A5002400320 @default.
• W2963855109 creator A5005250000 @default.
• W2963855109 creator A5007575010 @default.
• W2963855109 creator A5013485701 @default.
• W2963855109 creator A5015740152 @default.
• W2963855109 creator A5017771299 @default.
• W2963855109 creator A5021860279 @default.
• W2963855109 creator A5039778094 @default.
• W2963855109 creator A5042523454 @default.
• W2963855109 creator A5045226512 @default.
• W2963855109 creator A5056702454 @default.
• W2963855109 creator A5058429184 @default.
• W2963855109 creator A5061441951 @default.
• W2963855109 creator A5062403027 @default.
• W2963855109 creator A5073395286 @default.
• W2963855109 creator A5077698155 @default.
• W2963855109 creator A5079802303 @default.
• W2963855109 creator A5083131544 @default.
• W2963855109 creator A5089714563 @default.
• W2963855109 date "2019-10-01" @default.
• W2963855109 modified "2023-10-16" @default.
• W2963855109 title "Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018" @default.
• W2963855109 cites W1489963450 @default.
• W2963855109 cites W1549611683 @default.
• W2963855109 cites W1606648030 @default.
• W2963855109 cites W1856370515 @default.
• W2963855109 cites W1968735621 @default.
• W2963855109 cites W1972912578 @default.
• W2963855109 cites W1979811833 @default.
• W2963855109 cites W1980119010 @default.
• W2963855109 cites W2005601855 @default.
• W2963855109 cites W2014560120 @default.
• W2963855109 cites W2016006304 @default.
• W2963855109 cites W2024548912 @default.
• W2963855109 cites W2040818579 @default.
• W2963855109 cites W2046581108 @default.
• W2963855109 cites W2059748716 @default.
• W2963855109 cites W2060432974 @default.
• W2963855109 cites W2065741177 @default.
• W2963855109 cites W2066937933 @default.
• W2963855109 cites W2067283190 @default.
• W2963855109 cites W2069967309 @default.
• W2963855109 cites W2070309415 @default.
• W2963855109 cites W2078378191 @default.
• W2963855109 cites W2081084828 @default.
• W2963855109 cites W2084095675 @default.
• W2963855109 cites W2096544053 @default.
• W2963855109 cites W2097939049 @default.
• W2963855109 cites W2098903169 @default.
• W2963855109 cites W2100501133 @default.
• W2963855109 cites W2107270081 @default.
• W2963855109 cites W2110707581 @default.
• W2963855109 cites W2113046540 @default.
• W2963855109 cites W2119319209 @default.
• W2963855109 cites W2121380279 @default.
• W2963855109 cites W2121762104 @default.
• W2963855109 cites W2127307826 @default.
• W2963855109 cites W2128628205 @default.
• W2963855109 cites W2131952914 @default.
• W2963855109 cites W2137467802 @default.
• W2963855109 cites W2140525590 @default.
• W2963855109 cites W2141454098 @default.
• W2963855109 cites W2142016013 @default.
• W2963855109 cites W2142466432 @default.
• W2963855109 cites W2148643283 @default.
• W2963855109 cites W2150865892 @default.
• W2963855109 cites W2160129915 @default.
• W2963855109 cites W2161306413 @default.
• W2963855109 cites W2165088640 @default.
• W2963855109 cites W2165246410 @default.
• W2963855109 cites W2166918329 @default.
• W2963855109 cites W2169700609 @default.
• W2963855109 cites W2214621962 @default.
• W2963855109 cites W2219580045 @default.
• W2963855109 cites W2266520230 @default.
• W2963855109 cites W2278392405 @default.
• W2963855109 cites W2283896427 @default.
• W2963855109 cites W2285201826 @default.
• W2963855109 cites W2285876816 @default.
• W2963855109 cites W2345296224 @default.
• W2963855109 cites W2346061096 @default.
• W2963855109 cites W2346524736 @default.
• W2963855109 cites W2407997809 @default.
• W2963855109 cites W2431653148 @default.
• W2963855109 cites W2461508503 @default.
• W2963855109 cites W2471050799 @default.
• W2963855109 cites W2479762267 @default.
• W2963855109 cites W2499218207 @default.
• W2963855109 cites W2511358444 @default.
• W2963855109 cites W2531934133 @default.
• W2963855109 cites W2536093784 @default.
• W2963855109 cites W2566433825 @default.
• W2963855109 cites W2580246337 @default.
• W2963855109 cites W2585109238 @default.

• next